Nama Insights

Quest Diagnostics Incorporated (DGX)

Healthcare · Diagnostics Research · NYSE

S&P 500
Quest Diagnostics Incorporated (DGX) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $26.31B, a trailing price-to-earnings ratio of 22.4 and a free-cash-flow yield of 5.0%. Over the most recent reported fiscal year, revenue grew 11.8% and free cash flow per share grew 49.5%.
Market cap$26.31B
Trailing P/E22.4
FCF yield5.0%
Revenue growth (YoY)+11.8%
EPS growth (YoY)+10.4%
FCF/share growth (YoY)+49.5%
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics Research
Explore live DGX data on Nama Insights →

Recent Congressional trades

Quest Diagnostics Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Julia Letlow House Sell $1,001 - $15,000 Aug 11, 2025
Carol Devine Miller House Sell $1,001 - $15,000 Apr 11, 2025
Earl Blumenauer House Sell $1,001 - $15,000 May 3, 2024
Thomas R Carper Senate Buy $1,001 - $15,000
Earl Blumenauer House Buy $1,001 - $15,000 Apr 2, 2020
Dean Phillips House Buy $1,001 - $15,000 Feb 5, 2020
Dean Phillips House Buy $1,001 - $15,000 Jun 7, 2019
K. Michael Conaway House Sell $1,001 - $15,000 Sep 15, 2016
Lois Frankel House Sell $1,001 - $15,000 Jun 20, 2016
Richard L. Hanna House Sell $1,001 - $15,000 Nov 6, 2014
Richard L. Hanna House Sell $1,001 - $15,000 Jan 9, 2014